Stempeutics Anticipates Japan Approval For Stem Cell Therapy
29 Oct 2025 //
ECONOMICTIMES
MEDINET, Stempeutics Ink Stempeucel Option License in Japan
27 Oct 2025 //
EXPRESSPHARMA
Phase 3 Results for Stempeutics Cell Therapy in Knee Osteoarthritis Published
23 Aug 2023 //
BUSINESSWIRE
Alkem and Stempeutics launch StemOne for treatment of knee osteoarthritis
19 Sep 2022 //
ECONOMIC TIMES
Stempeutics begins DCGI approved phase 3 trial for Covid-19 patients with ARDS
19 Jan 2022 //
PHARMABIZ

Market Place
Sourcing Support